Jed Latkin | Chief Executive Officer, Chief Financial Officer and Chief Operating Officer |
Michael Rosol | Chief Medical Officer |
Erika Eves | Vice President of Finance and Administration |
William Regan | Chief Compliance Officer |
Michael Okunewitch | Maxim Group LLC |
Greetings, and welcome to Navidea Biopharmaceuticals Second Quarter 2021 Earnings Conference Call and Business Update. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jed Latkin, Chief Executive Officer.